title: Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection.
abstract: OBJECTIVE
  Little is known about resolution of serum and cerebrospinal fluid abnormalities after neurosyphilis treatment, especially in patients infected with human immunodeficiency virus (HIV).
  
  
  OBJECTIVE
  To examine the time course of resolution of these abnormalities.
  
  
  METHODS
  Case series of 22 patients with neurosyphilis (13 infected with HIV) with reactive cerebrospinal fluid Venereal Disease Research Laboratory test who underwent at least one lumbar puncture after treatment.
  
  
  RESULTS
  Resolution of all serum and cerebrospinal fluid measures was slower in patients infected with HIV. Serum and cerebrospinal fluid abnormalities resolved in most patients not infected with HIV by 30 weeks, and all met Centers for Disease Control and Prevention criteria for cure. One patient infected with HIV failed therapy by Centers for Disease Control and Prevention criteria, and three others had persistent pleocytosis.
  
  
  CONCLUSIONS
  HIV-infected patients with neurosyphilis have slower resolution of serum and cerebrospinal fluid abnormalities after therapy. This observation may suggest impaired clearance of Treponema pallidum from the central nervous system.
authors.affiliation: Division of Neurology, School of Medicine, University of Washington, Seattle, USA.
authors.forename: C M
authors.initials: CM
authors.lastname: Marra
authors.forename: W T
authors.initials: WT
authors.lastname: Longstreth
authors.forename: C L
authors.initials: CL
authors.lastname: Maxwell
authors.forename: S A
authors.initials: SA
authors.lastname: Lukehart
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood / Q000134:cerebrospinal fluid; D002556:Cerebrospinal Fluid Proteins / Q000134:cerebrospinal fluid; D015658:HIV Infections / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000150:complications / Q000188:drug therapy; D006801:Humans; D018655:Lymphocyte Count; D009494:Neurosyphilis / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000150:complications / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D014210:Treponema pallidum / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D002556:Cerebrospinal Fluid Proteins; D010406:Penicillins